Skip to main content
. 2008 Nov 4;99(11):1867–1873. doi: 10.1038/sj.bjc.6604756

Table 1. Characteristics of CRC patients.

    MSA status
 
  Total MSI-H MSS P-valuea
Number of patients n=70 n=37 (52.9) n=33 (47.1)  
Age (years; median, range) 50 (29–82)b 51 (29–82) 49 (29–73) 0.92
         
Gender 0.16
 Male 36 (51.4) 16 (43.2) 20 (60.6)  
 Female 34 (48.6) 21 (56.8) 13 (39.4)  
         
Localisation <0.001
 Proximal 31 (44.3) 24 (64.9) 7 (21.2)  
 Distal 28 (40.0) 6 (16.2) 22 (66.7)  
 NA 11 (15.7) 7 (18.9) 4 (12.1)  
         
Primary tumour 0.37
 T1 4 (5.7) 2 (5.4) 2 (6.1)  
 T2 13 (18.6) 4 (10.8) 9 (27.3)  
 T3 41 (58.6) 24 (64.9) 17 (51.5)  
 T4 8 (11.4) 4 (10.8) 4 (12.1)  
 Tx 4 (5.7) 3 (8.1) 1 (3.0)  
         
Lymph node status 0.94
 N0 32 (45.7) 17 (46.0) 15 (45.5)  
 N1/N2 27 (38.6) 16 (43.2) 11 (33.3)  
 Nx 11 (15.7) 4 (10.8) 7 (21.2)  
         
Distant metastasis 0.49
 M0 42 (60) 27 (73) 15 (45.5)  
 M1 8 (11.4) 4 (10.8) 4 (12.1)  
 Mx 20 (28.6) 6 (16.2) 14 (42.4)  
         
Stage of disease (UICC) 0.64
 I 10 (14.3) 5 (13.5) 5 (15.2)  
 II 17 (24.3) 11 (29.7) 6 (18.2)  
 III 14 (20.0) 10 (27.0) 4 (12.1)  
 IV 8 (11.4) 4 (10.8) 4 (12.1)  
 NA 21 (30.0) 7 (18.9) 14 (42.4)  

NA=not analysable.

a

Fisher's exact test for categorical data and the Mann–Whitney test for age.

b

Numbers in parentheses indicate percentage values if not otherwise indicated.